NO20000087L - Behandling av inflammatoriske sykdommer i tarmen og urinblære - Google Patents

Behandling av inflammatoriske sykdommer i tarmen og urinblære

Info

Publication number
NO20000087L
NO20000087L NO20000087A NO20000087A NO20000087L NO 20000087 L NO20000087 L NO 20000087L NO 20000087 A NO20000087 A NO 20000087A NO 20000087 A NO20000087 A NO 20000087A NO 20000087 L NO20000087 L NO 20000087L
Authority
NO
Norway
Prior art keywords
inflammatory diseases
treatment
bladder
intestine
procedures
Prior art date
Application number
NO20000087A
Other languages
English (en)
Norwegian (no)
Other versions
NO20000087D0 (no
Inventor
Jerome Zeldis
Susan Mclaughlin
Bruce Stouch
Robert Knobler
Original Assignee
Therakos Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therakos Inc filed Critical Therakos Inc
Publication of NO20000087D0 publication Critical patent/NO20000087D0/no
Publication of NO20000087L publication Critical patent/NO20000087L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A61M2202/0439—White blood cells; Leucocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
    • A61M2205/051—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20000087A 1997-07-10 2000-01-07 Behandling av inflammatoriske sykdommer i tarmen og urinblære NO20000087L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5210197P 1997-07-10 1997-07-10
PCT/US1998/014118 WO1999002215A1 (en) 1997-07-10 1998-07-08 Treatment of inflammatory disorders of the bowel and urinary bladder

Publications (2)

Publication Number Publication Date
NO20000087D0 NO20000087D0 (no) 2000-01-07
NO20000087L true NO20000087L (no) 2000-03-09

Family

ID=21975478

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000087A NO20000087L (no) 1997-07-10 2000-01-07 Behandling av inflammatoriske sykdommer i tarmen og urinblære

Country Status (19)

Country Link
US (1) US5985914A (da)
EP (1) EP0994743B1 (da)
JP (1) JP4166432B2 (da)
KR (1) KR100541784B1 (da)
CN (1) CN1230212C (da)
AT (1) ATE327800T1 (da)
AU (1) AU752616B2 (da)
CA (1) CA2295572C (da)
DE (1) DE69834724T2 (da)
DK (1) DK0994743T3 (da)
ES (1) ES2265664T3 (da)
HK (1) HK1030891A1 (da)
HU (1) HUP0004089A2 (da)
IL (2) IL133913A0 (da)
NO (1) NO20000087L (da)
NZ (1) NZ524459A (da)
PL (1) PL196145B1 (da)
PT (1) PT994743E (da)
WO (1) WO1999002215A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL133913A0 (en) * 1997-07-10 2001-04-30 Therakos Inc Treatment of inflammatory disorders of the bowel and urinary bladder
US8722422B2 (en) 1999-09-03 2014-05-13 Therakos, Inc. Uninterrupted flow pump apparatus and method
US6495366B1 (en) * 1999-09-03 2002-12-17 Therakos, Inc. Uninterrupted flow pump apparatus and method
WO2002060376A2 (en) * 2001-01-31 2002-08-08 Tolaren Induction of tolerance by apoptotic and/or necrotic cells
US20050202098A1 (en) * 2001-01-31 2005-09-15 Tolaren Disease therapy using dying or dead cells
US20030139466A1 (en) * 2001-11-29 2003-07-24 Peritt David L. Methods for pretreating a subject with extracorporeal photopheresis
US20040127840A1 (en) 2002-03-04 2004-07-01 Steve Gara Blood separation apparatus and method of using the same
US7479123B2 (en) 2002-03-04 2009-01-20 Therakos, Inc. Method for collecting a desired blood component and performing a photopheresis treatment
GB0216650D0 (en) * 2002-07-18 2002-08-28 Univ Bristol Detection of disease by analysis of emissions
KR20070089980A (ko) * 2004-12-02 2007-09-04 아이시스 파마수티컬즈 인코포레이티드 염증성 장 질환의 치료를 위한 치료용 안티센스올리고뉴클레오티드 조성물
WO2007004045A2 (en) * 2005-07-05 2007-01-11 Universite De Lausanne Use of a photosensitizing agent in the treatment or prevention of an inflammation-associated disorder in the gastrointestinal tract of a mammal
CN101351118B (zh) 2005-11-02 2015-05-27 特拉科斯有限公司 凋亡细胞在离体产生调节t细胞中的应用
EP2021493A4 (en) 2006-05-02 2010-04-14 Therakos Inc METHOD AND REAGENTS FOR DETECTING NECESSITY FOR TRANSPLANT-RECEPTACLE DISEASE OR TRANSPLANT-MORTALITY
EP2042179A1 (en) * 2007-09-26 2009-04-01 sanofi-aventis Novel therapeutic uses of adrenergic alpha-1 receptor antagonists
US9399093B2 (en) * 2012-01-27 2016-07-26 Fenwal, Inc. Systems and methods for performing online extracorporeal photopheresis
DE102013101989A1 (de) * 2013-02-28 2014-09-18 B. Braun Avitum Ag Fuzzy-Logik
WO2016164821A1 (en) * 2015-04-08 2016-10-13 Schoellhammer Carl Magnus Systems, apparatus, and assembling method thereof for administering a substance
EP4077639B1 (en) * 2019-12-20 2024-06-12 Mallinckrodt Pharmaceuticals Ireland Limited Method for generating immunoregulatory cells in a blood-derived sample

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196281A (en) * 1976-10-20 1980-04-01 Regents Of The University Of California Psoralens
IT1088554B (it) * 1977-11-17 1985-06-10 F I D I A Spa Procedimento sellettivo per la preparazione di derivati della 7-indrossi cumarina
US4428744A (en) * 1979-12-11 1984-01-31 Frederic A. Bourke, Jr. Method and system for externally treating the blood
US4398906A (en) * 1979-12-11 1983-08-16 Frederic A. Bourke, Jr. Method for externally treating the blood
US4321919A (en) * 1979-12-11 1982-03-30 Leukocyte Research, Inc. Method and system for externally treating human blood
US4464166A (en) * 1981-06-12 1984-08-07 Frederic A. Bourke, Jr. Method for externally treating the blood
US4612007A (en) * 1981-06-16 1986-09-16 Edelson Richard Leslie Method and system for externally treating the blood
FR2521998B1 (fr) * 1982-02-25 1985-10-25 Inst Nat Sante Rech Med Pyrido (3,4-c) psoralenes, obtention, applications en cosmetologie et a titre de medicaments et compositions cosmetiques et pharmaceutiques les contenant
FR2521999B1 (fr) * 1982-02-25 1984-05-25 Inst Nat Sante Rech Med Pyrido (3',4' : 4,5) furo (3,2-g) coumarines ou pyrido (3,4-h) psoralenes, obtention, applications en cosmetologie et a titre de medicaments, et compositions cosmetiques et pharmaceutiques les contenant
US4684521A (en) * 1982-12-08 1987-08-04 Frederic A. Bourke, Jr. Method and system for externally treating the blood
US4613322A (en) * 1982-12-08 1986-09-23 Edelson Richard Leslie Method and system for externally treating the blood
US4683889A (en) * 1983-03-29 1987-08-04 Frederic A. Bourke, Jr. Method and system for externally treating the blood
US4748120A (en) * 1983-05-02 1988-05-31 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US5176921A (en) * 1983-05-02 1993-01-05 Diamond Scientific Co. Method of blood component decontamination by glucose addition
US4727027A (en) * 1983-05-02 1988-02-23 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US4693981A (en) * 1983-12-20 1987-09-15 Advanced Genetics Research Institute Preparation of inactivated viral vaccines
US4578056A (en) * 1984-10-29 1986-03-25 Extracorporeal Medical Specialties, Inc. Patient photopheresis treatment apparatus and method
US4708715A (en) * 1984-10-29 1987-11-24 Mcneilab, Inc. Light array assembly for photoactivation patient treatment system
US4737140A (en) * 1984-10-29 1988-04-12 Mcneilab, Inc. Irradiation chamber for photoactivation patient treatment system
US4573961A (en) * 1984-10-29 1986-03-04 Extracorporeal Medical Specialties, Inc. Electronic control methods for puvapheresis apparatus
US4623328A (en) * 1984-10-29 1986-11-18 Mcneilab, Inc. Pump monitor for photoactivation patient treatment system
US4568328A (en) * 1984-10-29 1986-02-04 Extracorporeal Medical Specialties, Inc. Automated photophoresis blood portion control methods and apparatus
US4596547A (en) * 1984-10-29 1986-06-24 Mcneilab, Inc. Valve apparatus for photoactivation patient treatment system
US4681568A (en) * 1984-10-29 1987-07-21 Mcneilab, Inc. Valve apparatus for photoactivation patient treatment system
US4705498A (en) * 1984-10-29 1987-11-10 Mcneilab, Inc. Disposable temperature probe for photoactivation patient treatment system
US4687464A (en) * 1984-10-29 1987-08-18 Mcneilab, Inc. Zero insertion force socket for photoactivation patient treatment system
US4643710A (en) * 1984-10-29 1987-02-17 Mcneilab, Inc. Valve apparatus for photoactivation patient treatment system
US4573962A (en) * 1984-10-29 1986-03-04 Extracorporeal Medical Specialties, Inc. Cassette drawer assembly for photoactivation patient treatment system
US4573960A (en) 1984-10-29 1986-03-04 Extracorporeal Medical Specialties, Inc. Three phase irradiation treatment process
US4692138A (en) * 1984-10-29 1987-09-08 Mcneilab, Inc. Pump block for interfacing irradiation chamber to photoactivation patient treatment system
USD298567S (en) 1986-02-27 1988-11-15 Mcneilab, Inc. Flexible patient fluid container
USD299953S (en) 1986-02-27 1989-02-21 Mcneilab, Inc. Control panel for a patient photophoresis treatment unit
US4897789A (en) * 1986-02-27 1990-01-30 Mcneilab, Inc. Electronic device for authenticating and verifying disposable elements
USD298279S (en) 1986-02-27 1988-10-25 Mcneilab, Inc. Disposable patient fluid irradiation chamber
USD299531S (en) 1986-02-27 1989-01-24 Mcneilab, Inc. Patient photopheresis treatment unit
US4866282A (en) * 1986-08-26 1989-09-12 Baxter International Inc. Irradiation of blood products
US4726949A (en) * 1986-08-26 1988-02-23 Baxter Travenol Laboratories, Inc. Irradiation of blood products
US4952812A (en) * 1986-08-26 1990-08-28 Baxter International Inc. Irradiation of blood products
US4838852A (en) * 1987-03-27 1989-06-13 Therakos, Inc. Active specific immune suppression
US4878891A (en) * 1987-06-25 1989-11-07 Baylor Research Foundation Method for eradicating infectious biological contaminants in body tissues
US4960408A (en) * 1989-01-10 1990-10-02 Klainer Albert S Treatment methods and vaccines for stimulating an immunological response against retroviruses
US5356929A (en) * 1989-01-23 1994-10-18 Lehigh University Reduced and quaternized psoralens as photo-activated therapeutics
US5216176A (en) * 1989-01-23 1993-06-01 Lehigh University 7-alkoxycoumarins, dihydropsoralens, and benzodipyranones as photo-activated therapeutic agents and inhibitors of epidermal growth factor
US4921473A (en) * 1989-02-02 1990-05-01 Therakos, Inc. Multicomponent fluid separation and irradiation system
US4999375A (en) * 1989-04-11 1991-03-12 Hoffmann-La Roche Inc. Psoralen reagent compositions for extracorporeal treatment of blood
US5383847A (en) * 1990-03-29 1995-01-24 Therakos, Inc. Non-specific immune system enhancement
ES2110002T3 (es) * 1991-06-21 1998-02-01 Baxter Int Procedimiento de inactivacion de agentes patogenos en fluidos corporales.
DE69330514T2 (de) * 1992-01-27 2002-03-28 Baxter International Inc., Deerfield Verfahren zur inaktivierung von viralen, parasitären und bakteriellen blutverunreinigungen
US5288605A (en) * 1992-03-02 1994-02-22 Steritech, Inc. Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen
US5459030A (en) * 1992-03-02 1995-10-17 Steritech, Inc. Synthetic media compositions for inactivating bacteria and viruses in blood preparations with 8-methoxypsoralen
IL105741A0 (en) * 1992-05-22 1993-09-22 Genta Inc Pharmaceutical compositions for treating cellular hyperproliferation using interleukin-1 inhibitory compounds
EP0653911B1 (en) * 1992-08-07 2000-05-17 Cerus Corporation Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen
US5820872A (en) * 1992-11-18 1998-10-13 Yale University Methods and compositions for improving the effectiveness of X-irradiation therapy for the treatment of an internal solid tumor
US5651993A (en) * 1992-11-18 1997-07-29 Yale University Specific immune system modulation
US5368841A (en) * 1993-02-11 1994-11-29 The General Hospital Corporation Photodynamic therapy for the destruction of the synovium in the treatment of rheumatoid arthritis and the inflammatory arthritides
US5399719A (en) * 1993-06-28 1995-03-21 Steritech, Inc. Compounds for the photodecontamination of pathogens in blood
WO1997036581A1 (en) * 1996-03-29 1997-10-09 Therakos, Inc. Photopheresis treatment of leukocytes
IL133913A0 (en) * 1997-07-10 2001-04-30 Therakos Inc Treatment of inflammatory disorders of the bowel and urinary bladder

Also Published As

Publication number Publication date
JP4166432B2 (ja) 2008-10-15
WO1999002215A1 (en) 1999-01-21
DK0994743T3 (da) 2006-10-02
AU8386498A (en) 1999-02-08
NZ524459A (en) 2004-11-26
ES2265664T3 (es) 2007-02-16
CA2295572C (en) 2010-07-06
DE69834724D1 (de) 2006-07-06
IL133913A (en) 2009-09-01
KR20010021630A (da) 2001-03-15
CN1266375A (zh) 2000-09-13
ATE327800T1 (de) 2006-06-15
EP0994743A1 (en) 2000-04-26
HUP0004089A2 (hu) 2001-04-28
CN1230212C (zh) 2005-12-07
JP2001509427A (ja) 2001-07-24
NO20000087D0 (no) 2000-01-07
EP0994743A4 (en) 2001-02-14
PL338071A1 (en) 2000-09-25
IL133913A0 (en) 2001-04-30
US5985914A (en) 1999-11-16
KR100541784B1 (ko) 2006-01-10
AU752616B2 (en) 2002-09-26
CA2295572A1 (en) 1999-01-21
EP0994743B1 (en) 2006-05-31
PL196145B1 (pl) 2007-12-31
PT994743E (pt) 2006-08-31
HK1030891A1 (en) 2001-05-25
DE69834724T2 (de) 2007-05-24

Similar Documents

Publication Publication Date Title
NO20000087L (no) Behandling av inflammatoriske sykdommer i tarmen og urinblære
ATE281839T1 (de) Behandlung des kongestiven herzversagens durch vorbehandeltes autologes blut
ID24901A (id) Metode pengobatan keadaan terkoagulasi tinggi atau defisiensi protein c yang diperoleh
UA84665C2 (ru) Способ ингибирования опосредствованного ангиогенеза в ткани у пациента с неоваскулярным заболеванием роговицы
PT638075E (pt) Inibidor da reaccao de maillard
DE59600683D1 (de) Verwendung von Trospiumchlorid zur Herstellung eines Arzneimittels zur Behandlung von Blasenkrankheiten
AU2544197A (en) Photopheresis treatment of chronic hcv infections
NO20005757L (no) Cabergolin og pramipexol - nye anvendelser og kombinasjoner
SU1708361A1 (ru) Способ лечени острого гематогенного остеомиелита у детей
RU2000100938A (ru) Лечение воспалительных заболеваний кишечника и мочевого пузыря
RU93025693A (ru) Способ хирургического лечения близорукости
RU94036741A (ru) Способ защиты головного мозга от гипоксии при хирургическом лечении окклюзионных двухсторонних поражений сонных артерий и недостаточной функции коллатерального кровообращения
RU93039009A (ru) Способ лечения больных гипертонической болезнью
RU95102717A (ru) Способ лечения гнойно-септических осложнений в хирургии
RU95108457A (ru) Способ лечения тяжелых форм глпс
RU96117545A (ru) Способ лечения диабетической ретинопатии
RU95102184A (ru) Способ лечения синдрома после тотальной оварэктомии
RU93006338A (ru) Устройство для вытяжения позвоночника
RU93035257A (ru) Способ лечения болезни пайра
RU95110381A (ru) Способ лечения заболеваний сосудов
RU94025749A (ru) Способ оперативного лечения дуоденостаза
RU93045689A (ru) Способ лечения хронической артериальной недостаточности конечностей
RU97111211A (ru) Способ лечения больных с хирургическим эндотоксикозом
RU95109601A (ru) Способ лечения токсических форм дифтерии
RU95100165A (ru) Способ лечения прогрессирующей близорукости

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application